We honor 100 of the leading innovators in pathology and laboratory medicine by celebrating their success at the cutting edge of the field.
Can you determine the hereditary syndrome that this renal tumor is indicative of?
The FLEX breast cancer registry intends to collect complete information on 10,000 patients over the course of 10 years
George Vasmatzis and John Cheville
Newly discovered genetic alterations could indicate whether treatment or active surveillance is the best option for low-risk prostate cancer patients
Luxembourg’s new molecular diagnostics program aims to establish the value of such analyses as a part of routine cancer care
For regions with limited infrastructure, a device that can diagnose Kaposi’s sarcoma without the need for a steady power supply could be invaluable
An electronic gas-sensing capsule may increase diagnostic and monitoring accuracy in disorders of the digestive tract
Can you diagnose this testicular mass and decide which histologic finding incurs the worst prognosis?
A newly discovered chromosome signature offers hope to children with medulloblastoma who may not need intense therapy
A two-stage model featuring point of care sepsis testing and follow-up lab results could improve treatment and reduce the risk of mortality
Niamh Buckley, Laura Feeney, James Beirne, and Paul Mullan
Markers such as DNA methylation, analyzed by liquid biopsy, may improve on ovarian cancer testing options like gold standard CA125
Send me the latest from The Pathologist.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.